Verona Pharma is one of ReViral's top rivals. Verona Pharma's headquarters is in London, England, and was founded in 2005. Like ReViral, Verona Pharma also competes in the Biotechnology industry. Verona Pharma generates 900% of ReViral's revenue.
Enterprise Therapeutics has been one of ReViral's top competitors. Enterprise Therapeutics was founded in 2014 in Brighton, England. Like ReViral, Enterprise Therapeutics also operates in the Biotechnology field. Enterprise Therapeutics generates $24M less revenue than ReViral.